Company news

Avicanna Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Avicanna Enters Agreement to Develop and License Cannabinoid Tablet Formulations for US Distributor Partner

September 29, 2020

Avicanna's RHO Phyto(TM) Rapid Act Sprays are Now Available Nation Wide in Canada Through Medical Cannabis by Shoppers(TM)

September 21, 2020

Avicanna's subsidiary obtains GPP certification and authorization by INVIMA for the compounding and sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia

September 14, 2020

Avicanna Advances its Supply Chain Business and Announces Filing of Amended Interim Financial Statements

September 4, 2020

Avicanna Advances its Supply Chain Business with Commercial Exports of CBG And CBD into the United States and Germany as well as Industrial Scale THC Quota Granted by the Colombian Authorities

August 24, 2020

Avicanna Closes Non-Brokered Private Placement Raising $2.7 Million

August 18, 2020

Avicanna Reports Second Quarter 2020 Financial Results and Provides Corporate Update

August 17, 2020

Avicanna's RHO Phyto(TM) Medical Product Line is Now Available Nation-Wide in Canada Through Medical Cannabis by Shoppers Inc.(TM)

August 12, 2020

Avicanna and Red White & Bloom Enter Exclusive Partnership for the Distribution and Commercialization of Pura H&W Hemp-Derived CBD-Based Topical Products in the United States

August 11, 2020

Avicanna Inc. to Host Second Quarter 2020 Investor Conference Call

August 7, 2020

Avicanna announces the award of two Canadian government NSERC grants: 1) Cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 in collaboration with the University of Toronto; and, 2) Evaluation of cannabinoids for reversing cannabis-based toxicosis in collaboration with the University of Guelph

July 24, 2020

Avicanna Announces Participation in a Medical Cannabis Real-World Evidence (MC-RWE) Research Study Led by the University Health Network in Partnership with Medical Cannabis by Shoppers(TM) using its Rho Phyto(TM) Advanced Medical Cannabis Formulary of Products

July 15, 2020

Cannabis & CBD Biopharma Investor Presentations Now Available for On-Demand Viewing

July 10, 2020

Live Investor Conference & Webinar: Cannabis & CBD Biopharma Industry Companies Present July 9th

July 7, 2020

Avicanna Announces Co-development of a Cannabinoid-based Formulation for Treatment of COVID-19 related Lung Inflammation with Support from the Mitacs Accelerate Program

June 23, 2020

Avicanna to Host Virtual Symposium Titled "Medical Cannabis 2.0" on July 21st, 2020 in Partnership with Medical Cannabis By Shoppers(TM) in Anticipation of the Launch of its Rho Phyto(TM) Product Line

June 22, 2020

Avicanna Completes First Ever Export of Feminized Hemp Seeds For Cultivation Use to the United States and Closes the Initial Sale

June 18, 2020

Avicanna Successfully Registers the First Group of its Pura Earth(TM) CBD-Based Derma-Cosmetic Product Line in the European Union in Preparation for its Commercialization

June 9, 2020

Avicanna Reports First Quarter 2020 Financial Results and Provides Corporate Update

May 24, 2020

Avicanna to Postpone Reporting First Quarter 2020 Results Due to Delays Caused by COVID-19

May 14, 2020

Avicanna Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with World-Class Canadian Manufacturer MediPharm Labs

May 14, 2020

Avicanna Receives Government Support and Approval for First Ever Export of Hemp Seeds From Colombia

May 7, 2020

Avicanna Closes Non-Brokered Private Placement with Group of Strategic Investors and Announces Warrant Re-Pricing

April 21, 2020

Avicanna Reports Fourth Quarter 2019 Financial Results and Provides Corporate Update

April 15, 2020

Avicanna to Postpone Reporting Fourth Quarter and Full Year 2019 Results Due to Delays Caused by COVID-19

March 30, 2020

Avicanna to Supply Australian Market with Cannabis-Based Medicinal Products Through Distribution Agreement with Cannvalate

February 24, 2020

Avicanna Ranks Highest Amongst Global Cannabis Companies in the SAM Corporate Sustainability Assessment (CSA)

February 6, 2020

Avicanna Closes First Tranche of Private Placement

January 24, 2020

Avicanna Announces Appointment of Benjamin Leavenworth as Independent Director

January 21, 2020

Avicanna Announces the Successful Completion of its Clinical Study Evaluating the Effect of an Emollient Cream Containing 0.5% Cannabidiol on Skin Hydration

January 13, 2020

Avicanna Announces Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc., to Distribute Avicanna's Advanced and Evidence-based Medical Cannabis and Derma-Cosmetic Products Across Canada

January 10, 2020

Avicanna Enters Into USD$5 Million Revolving Credit Facility

December 27, 2019

Avicanna to Host Key Opinion Leader Meeting on the Use of Cannabinoids for the Treatment of Pain and Epilepsy

December 6, 2019

Avicanna Receives DTC Eligibility for Common Shares on OTCQX

December 5, 2019

Avicanna to Supply UK Market with Cannabis-Based Medicinal Products Through Distribution Agreement with the LYPHE Group

December 3, 2019

Avicanna's Rho Phyto Branded Products to be Available in California

December 1, 2019

Avicanna Announces Option to Purchase Newly Formed US Cannabis Operator

November 26, 2019

Avicanna Reports Third Quarter 2019 Financial Results

November 14, 2019

Avicanna Announces Voluntary Lock-Up Agreements for Key Insiders and Separation of CEO and Chairman Roles

October 29, 2019

Avicanna (TSX: AVCN) Completes First Commercial Exports of CBD to South Africa and the United Kingdom

October 24, 2019

Avicanna Announces Retail Launch of Pura Earth Derma-Cosmetics with Initial Roll-Out in Colombia

October 21, 2019

Avicanna (TSX: AVCN) Announces Receipt of the First Colombian USDA Organic Certification for its Hemp Cultivation and Registration of 15 Additional Genetics

October 18, 2019

Avicanna Commences Trading on the OTCQX Market in the United States

October 15, 2019

Avicanna (TSX: AVCN) Announces First Commercial Sale of the Pura Earth Derma-Cosmetics line of CBD Products

October 2, 2019

Avicanna (TSX: AVCN) to Open its Next Phase Extraction Facility in Colombia's Free Trade Zone

September 30, 2019

Avicanna (TSX: AVCN) Aras Azadian, CEO & Co-Founder to speak at the 12th Annual International Natural & Organic Cosmetics Conference About Organic CBD Skin Care and Pura Earth(TM) in Berlin, Germany

September 23, 2019

Avicanna (TSX: AVCN) Enters an Exclusive Research Agreement with the University of Guelph for Proprietary Cannabinoid-based Products and Formulations to Treat Psychiatric Disorders

September 13, 2019

Avicanna (TSX: AVCN) Further Strengthens its Position as a Canadian Leader in Cannabinoid Based Research and Development with Expansion of University of Toronto Collaboration and Execution of University of Guelph Research Agreement

August 30, 2019

Avicanna (TSX: AVCN) Completes its First Exportation of Cannabinoids from Colombia to Canada for Scientific Purposes

August 23, 2019

Avicanna Secures Canadian Cannabinoid Research Licence at its Headquarters in Toronto's Discovery District

August 19, 2019

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 11 decks. Every deck is listed under its year.